Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Follitropin alfa 75unit inj vials
0605010I0AAAEAE
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 75units/0.125ml inj pf disposable devices
0605010I0AAAKAK
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 900units/1.44ml inj pf disposable devices
0605010I0AAAWAW
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 900units/1.5ml inj cartridges
0605010I0AAATAT
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin alfa 900units/1.5ml inj pre-filled syringes
0605010I0AAAJAJ
|
Follitropin alfa | Follitropin alfa | Endocrine System | No data available |
|
Follitropin beta 100units/0.5ml solution for injection vials
0605010K0AAAEAE
|
Follitropin beta | Follitropin beta | Endocrine System | No data available |
|
Follitropin beta 150units/0.5ml solution for injection vials
0605010K0AAAFAF
|
Follitropin beta | Follitropin beta | Endocrine System | No data available |
|
Follitropin beta 200units/0.5ml solution for injection vials
0605010K0AAAGAG
|
Follitropin beta | Follitropin beta | Endocrine System | No data available |
|
Follitropin beta 300units/0.36ml inj cartridges
0605010K0AAAHAH
|
Follitropin beta | Follitropin beta | Endocrine System | No data available |
|
Follitropin beta 50units/0.5ml solution for injection vials
0605010K0AAADAD
|
Follitropin beta | Follitropin beta | Endocrine System | No data available |
|
Follitropin beta 600units/0.72ml inj cartridges
0605010K0AAAIAI
|
Follitropin beta | Follitropin beta | Endocrine System | No data available |
|
Follitropin beta 900units/1.08ml inj cartridges
0605010K0AAAJAJ
|
Follitropin beta | Follitropin beta | Endocrine System | No data available |
|
Follitropin delta 12micrograms/0.36ml inj cartridges
0605010AFAAAAAA
|
Follitropin delta | Follitropin delta | Endocrine System | No data available |
|
Follitropin delta 12micrograms/0.36ml inj pf dispos dev
0605010AFAAADAD
|
Follitropin delta | Follitropin delta | Endocrine System | No data available |
|
Follitropin delta 36micrograms/1.08ml inj cartridges
0605010AFAAABAB
|
Follitropin delta | Follitropin delta | Endocrine System | No data available |
|
Follitropin delta 36micrograms/1.08ml inj pf dispos dev
0605010AFAAAFAF
|
Follitropin delta | Follitropin delta | Endocrine System | No data available |
|
Follitropin delta 72micrograms/2.16ml inj cartridges
0605010AFAAACAC
|
Follitropin delta | Follitropin delta | Endocrine System | No data available |
|
Follitropin delta 72micrograms/2.16ml inj pf dispos dev
0605010AFAAAEAE
|
Follitropin delta | Follitropin delta | Endocrine System | No data available |
|
Forsteo 20micrograms/80microlitres inj 3ml pf dispos dev
0606010U0BBAAAA
|
Forsteo | Teriparatide | Endocrine System | No data available |
|
Fosamax 10mg tablets
0606020A0BBAAAA
|
Fosamax | Alendronic acid | Endocrine System | No data available |
|
Fosamax 5mg tablets
0606020A0BBABAB
|
Fosamax | Alendronic acid | Endocrine System | No data available |
|
Fostimon 150unit inj vials
0605010M0BGABAF
|
Fostimon | Urofollitropin | Endocrine System | No data available |
|
Fostimon 75unit inj vials
0605010M0BGAAAE
|
Fostimon | Urofollitropin | Endocrine System | No data available |
|
Generic Climagest 1mg tablets
0604011L0AAAHAH
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Generic Climagest 2mg tablets
0604011L0AAAIAI
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.